Cargando…
The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study
The A2(A) receptor agonist, regadenoson, is increasingly used as a vasodilator during nuclear myocardial perfusion imaging. Regadenoson is administered as a single, fixed dose. Given the frequency of obesity in patients with symptoms of heart disease, it is important to know whether the fixed dose o...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463785/ https://www.ncbi.nlm.nih.gov/pubmed/21968545 http://dx.doi.org/10.1007/s10554-011-9949-4 |